Vascular endothelial growth factor (VEGF), produced by feline infectious peritonitis (FIP) virus-infected monocytes and macrophages, induces vascular permeability and effusion in cats with FIP

Virus Research

Volumn 158, Issue 1-2, 2011, Pages 161-168

  Takano, Tomomi ^a   Ohyama, Taku ^a   Kokumoto, Aiko ^a   Satoh, Ryoichi ^a   Hohdatsu, Tsutomu ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Coronavirus; Effusion; FIP; Macrophage; Monocyte; VEGF

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CAT; CONTROLLED STUDY; CORONAVIRUS; CORRELATION ANALYSIS; EFFUSION; ENDOTHELIUM CELL; FELINE INFECTIOUS PERITONITIS; GENE EXPRESSION PROFILING; LEUKOCYTE CULTURE; MACROPHAGE; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; SUPERNATANT; VIRUS REPLICATION;

ANIMALS; CAPILLARY PERMEABILITY; CATS; CELLS, CULTURED; CORONAVIRUS, FELINE; ENDOTHELIAL CELLS; FELINE INFECTIOUS PERITONITIS; MACROPHAGES; MONOCYTES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CORONAVIRUS; FELIDAE; FELINE INFECTIOUS PERITONITIS VIRUS;

EID: 79956322716     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.03.027     Document Type: Article

References (48)

1. Bragado R., Bello E., Requena L., Renedo G., Texeiro E., Alvarez M.V., Castilla M.A., Caramelo C. Increased expression of vascular endothelial growth factor in pyogenic granulomas. Acta Derm. Venereol. 1999, 79:422-425.
2. Brown M.A., Troyer J.L., Pecon-Slattery J., Roelke M.E., O'Brien S.J. Genetics and pathogenesis of feline infectious peritonitis virus. Emerg. Infect. Dis. 2009, 15:1445-1452.
3. Chang Y.H., de Groot R.J., Egberink H.F., Rottier P.J. Feline infectious peritonitis:insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J. Gen. Virol. 2010, 91:415-420.
4. Chen S.U., Chou C.H., Lee H., Ho C.H., Lin C.W., Yang Y.S. Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-kappaB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Metab. 2008, 93:935-943.
5. Corapi W.V., Olsen C.W., Scott F.W. Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J. Virol. 1992, 66:6695-6705.
6. Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P.C., Pan Y.C., Olander J.V., Connolly D.T., Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 1990, 172:1535-1545.
7. Dvorak H.F., Nagy J.A., Feng D., Brown L.F., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 1999, 237:97-132.
8. Dewerchin H.L., Cornelissen E., Nauwynck H.J. Replication of feline coronaviruses in peripheral blood monocytes. Arch. Virol. 2005, 150:2483-2500.
9. Fava R.A., Olsen N.J., Spencer-Green G., Yeo K.T., Yeo T.K., Berse B., Jackman R.W., Senger D.R., Dvorak H.F., Brown L.F. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 1994, 180:341-346.
10. Feurino L.W., Zhang Y., Bharadwaj U., Zhang R., Li F., Fisher W.E., Brunicardi F.C., Chen C., Yao Q., Min L. IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells. Cancer Biol. Ther. 2007, 6:1096-1100.
11. Gavrilovskaya I.N., Gorbunova E.E., Mackow N.A., Mackow E.R. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J. Virol. 2008, 82:5797-5806.
12. Gelain M.E., Meli M., Paltrinieri S. Whole blood cytokine profiles in cats infected by feline coronavirus and healthy non-FCoV infected specific pathogen-free cats. J. Feline Med. Surg. 2006, 8:389-399.
13. Goitsuka R., Ohashi T., Ono K., Yasukawa K., Koishibara Y., Fukui H., Ohsugi Y., Hasegawa A. IL-6 activity in feline infectious peritonitis. J. Immunol. 1990, 144:2599-2603.
14. Gunn-Moore D.A., Caney S.M., Gruffydd-Jones T.J., Helps C.R., Harbour D.A. Antibody and cytokine responses in kittens during the development of feline infectious peritonitis (FIP). Vet. Immunol. Immunopathol. 1998, 65:221-242.
15. Hayashi T., Goto N., Takahashi R., Fujiwara K. Systemic vascular lesions in feline infectious peritonitis. Nippon Juigaku Zasshi 1976, 39:365-377.
16. Hohdatsu T., Nakamura M., Ishizuka Y., Yamada H., Koyama H. A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies. Arch. Virol. 1991, 120:207-217.
17. Hohdatsu T., Yamada H., Ishizuka Y., Koyama H. Enhancement and neutralization of feline infectious peritonitis virus infection in feline macrophages by neutralizing monoclonal antibodies recognizing different epitopes. Microbiol. Immunol. 1993, 37:499-504.
18. Hu L., Hofmann J., Zaloudek C., Ferrara N., Hamilton T., Jaffe R.B. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer. Am. J. Pathol. 2002, 161:1917-1924.
19. Kipar A., May H., Menger S., Weber M., Leukert W., Reinacher M. Morphologic features and development of granulomatous vasculitis in feline infectious peritonitis. Vet. Pathol. 2005, 42:321-330.
20. Kiss I., Poland A.M., Pedersen N.C. Disease outcome and cytokine responses in cats immunized with an avirulent feline infectious peritonitis virus (FIPV)-UCD1 and challenge -exposed with virulent FIPV-UCD8. J. Feline Med. Surg. 2004, 6:89-97.
21. Koga L., Kobayashi Y., Yazawa M., Maeda S., Masuda K., Ohno K., Tsujimoto H. Nucleotide sequence and expression of the feline vascular endothelial growth factor. J. Vet. Med. Sci. 2002, 64:453-456.
22. Kraft A., Weindel K., Ochs A., Marth C., Zmija J., Schumacher P., Unger C., Marmé D., Gastl G. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 1999, 85:178-187.
23. Li C.G., Reynolds I., Ponting J.M., Holt P.J., Hillarby M.C., Kumar S. Serum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener's granulomatosis. Br. J. Rheumatol. 1998, 37:1303-1306.
24. Lyttle D.J., Fraser K.M., Fleming S.B., Mercer A.A., Robinson A.J. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J. Virol. 1994, 68:84-92.
25. Maeno N., Takei S., Masuda K., Akaike H., Matsuo K., Kitajima I., Maruyama I., Miyata K. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr. Res. 1998, 44:596-599.
26. Mesiano S., Ferrara N., Jaffe R.B. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am. J. Pathol. 1998, 153:1249-1256.
27. Motokawa K., Hohdatsu T., Aizawa C., Koyama H., Hashimoto H. Molecular cloning and sequence determination of the peplomer protein gene of feline infectious peritonitis virus type I. Arch. Virol. 1995, 140:469-480.
28. Motokawa K., Hohdatsu T., Hashimoto H., Koyama H. Comparison of the amino acid sequence and phylogenetic analysis of the peplomer, integral membrane and nucleocapsid proteins of feline, canine and porcine coronaviruses. Microbiol. Immunol. 1996, 40:425-433.
29. Olsen C.W., Corapi W.V., Ngichabe C.K., Baines J.D., Scott F.W. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. J. Virol. 1992, 66:956-965.
30. Pedersen N.C. A review of feline infectious peritonitis virus infection: 1963-2008. J. Feline Med. Surg. 2009, 11:225-258.
31. Pedersen N.C., Boyle J.F. Immunologic phenomena in the effusive form of feline infectious peritonitis. Am. J. Vet. Res. 1980, 41:868-876.
32. Poland A.M., Vennema H., Foley J.E., Pedersen N.C. Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus. J. Clin. Microbiol. 1996, 34:3180-3184.
33. Regan A.D., Cohen R.D., Whittaker G.R. Activation of p38 MAPK by feline infectious peritonitis virus regulates pro-inflammatory cytokine production in primary blood-derived feline mononuclear cells. Virology 2009, 384:135-143.
34. Ryan U.S. Isolation and culture of pulmonary endothelial cells. Environ. Health Perspect. 1984, 56:103-114.
35. Stathopoulos G.T., Kollintza A., Moschos C., Psallidas I., Sherrill T.P., Pitsinos E.N., Vassiliou S., Karatza M., Papiris S.A., Graf D., Orphanidou D., Light R.W., Roussos C., Blackwell T.S., Kalomenidis I. Tumor necrosis factor-alpha promotes malignant pleural effusion. Cancer Res. 2007, 67:9825-9834.
36. Stoddart C.A., Scott F.W. Intrinsic resistance of feline peritoneal macrophages to coronavirus infection correlates with in vivo virulence. J. Virol. 1989, 63:436-440.
37. Takano T., Azuma N., Hashida Y., Satoh R., Hohdatsu T. B-cell activation in cats with feline infectious peritonitis (FIP) by FIP-virus-induced B-cell differentiation/survival factors. Arch. Virol. 2009, 154:27-35.
38. Takano T., Azuma N., Satoh M., Toda A., Hashida Y., Satoh R., Hohdatsu T. Neutrophil survival factors (TNF-alpha, GM-CSF, and G-CSF) produced by macrophages in cats infected with feline infectious peritonitis virus contribute to the pathogenesis of granulomatous lesions. Arch. Virol. 2009, 154:775-781.
39. Takano T., Hohdatsu T., Hashida Y., Kaneko Y., Tanabe M., Koyama H. A "possible" involvement of TNF-alpha in apoptosis induction in peripheral blood lymphocytes of cats with feline infectious peritonitis. Vet. Microbiol. 2007, 119:121-131.
40. Takano T., Hohdatsu T., Toda A., Tanabe M., Koyama H. TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-induced macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages. Virology 2007, 364:64-72.
41. Takano T., Kawakami C., Yamada S., Satoh R., Hohdatsu T. Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection. J. Vet. Med. Sci. 2008, 70:1315-1321.
42. Tseng C.S., Lo H.W., Teng H.C., Lo W.C., Ker C.G. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 2005, 43:99-102.
43. Vennema H., Poland A., Foley J., Pedersen N.C. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 1998, 243:150-157.
44. Viac J., Pernet I., Schmitt D., Claudy A. Overexpression of circulating vascular endothelial growth factor (VEGF) in leukocytoclastic vasculitis. Arch. Dermatol. Res. 1999, 291:622-623.
45. Weiss R.C., Scott F.W. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp. Immunol. Microbiol. Infect. Dis. 1981, 4:175-189.
46. Weiss R.C., Scott F.W. Pathogenesis of feline infectious peritonitis: nature and development of viremia. Am. J. Vet. Res. 1981, 42:382-390.
47. Wen F.Q., Liu X., Manda W., Terasaki Y., Kobayashi T., Abe S., Fang Q., Ertl R., Manouilova L., Rennard S.I. TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids. J. Allergy Clin. Immunol. 2003, 111:1307-1318.
48. Yoshino Y., Aoyagi M., Tamaki M., Duan L., Morimoto T., Ohno K. Activation of [38p] MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells. Int. J. Oncol. 2006, 29:981-987.